Meng Jian-Biao, Lai Zhi-Zhen, Xu Xiu-Juan, Ji Chun-Lian, Hu Ma-Hong, Zhang Geng
Department of Intensive Care Unit, Tongde Hospital of Zhejiang Province, 234 Gucui Road, Hangzhou 310012, China.
Biomed Res Int. 2016;2016:7463130. doi: 10.1155/2016/7463130. Epub 2016 Dec 1.
. To investigate the effects of 72-hour early-initiated continuous venovenous hemofiltration (ECVVH) treatment in patients with septic-shock-induced acute respiratory distress syndrome (ARDS) (not acute kidney injury, AKI) with regard to serum E-selectin and measurements of lung function and hemodynamic stability. . This prospective nonblinded single institutional randomized study involved 51 patients who were randomly assigned to receive or not receive ECVVH, an ECVVH group ( = 24) and a non-ECVVH group ( = 27). Besides standard therapies, patients in ECVVH group underwent CVVH for 72 h. . At 0 and 24 h after initiation of treatment, arterial partial pressure of oxygen/fraction of inspired oxygen (PaO/FiO) ratio, extravascular lung water index (EVLWI), and E-selectin level were not significantly different between groups (all > 0.05). Compared to non-ECVVH group, PaO/FiO is significantly higher and EVLWI and E-selectin level are significantly lower in ECVVH group (all < 0.05) at 48 h and 72 h after initiation of treatment. The lengths of mechanical ventilation and stay in intensive care unit (ICU) were shorter in ECVVH group (all < 0.05), but there was no difference in 28-day mortality between two groups. . In patients with septic-shock-induced ARDS (not AKI), treatment with ECVVH in addition to standard therapies improves endothelial function, lung function, and hemodynamic stability and reduces the lengths of mechanical ventilation and stay in ICU.
为了研究72小时早期启动的持续静静脉血液滤过(ECVVH)治疗对脓毒性休克诱发的急性呼吸窘迫综合征(ARDS)(非急性肾损伤,AKI)患者血清E-选择素、肺功能及血流动力学稳定性测量指标的影响。 这项前瞻性非盲单中心随机研究纳入了51例患者,他们被随机分配接受或不接受ECVVH,分为ECVVH组(n = 24)和非ECVVH组(n = 27)。除标准治疗外,ECVVH组患者接受72小时的持续静脉-静脉血液滤过(CVVH)治疗。 在治疗开始后0小时和24小时,两组间动脉血氧分压/吸入氧分数(PaO₂/FiO₂)比值、血管外肺水指数(EVLWI)和E-选择素水平无显著差异(均P>0.05)。与非ECVVH组相比,治疗开始后48小时和72小时,ECVVH组的PaO₂/FiO₂显著更高,EVLWI和E-选择素水平显著更低(均P<0.05)。ECVVH组的机械通气时间和在重症监护病房(ICU)的住院时间更短(均P<0.05),但两组间28天死亡率无差异。 在脓毒性休克诱发的ARDS(非AKI)患者中,除标准治疗外,采用ECVVH治疗可改善内皮功能、肺功能和血流动力学稳定性,并缩短机械通气时间和在ICU的住院时间。